Correlation Between NLS Pharmaceutics and INVO Bioscience

Can any of the company-specific risk be diversified away by investing in both NLS Pharmaceutics and INVO Bioscience at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining NLS Pharmaceutics and INVO Bioscience into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between NLS Pharmaceutics AG and INVO Bioscience, you can compare the effects of market volatilities on NLS Pharmaceutics and INVO Bioscience and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in NLS Pharmaceutics with a short position of INVO Bioscience. Check out your portfolio center. Please also check ongoing floating volatility patterns of NLS Pharmaceutics and INVO Bioscience.

Diversification Opportunities for NLS Pharmaceutics and INVO Bioscience

0.16

Correlation Coefficient

NLS Pharmaceutics  INVO Bioscience

Average diversification

The 3 months correlation between NLS and INVO is 0.16. Overlapping area represents the amount of risk that can be diversified away by holding NLS Pharmaceutics AG and INVO Bioscience in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on INVO Bioscience and NLS Pharmaceutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on NLS Pharmaceutics AG are associated (or correlated) with INVO Bioscience. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of INVO Bioscience has no effect on the direction of NLS Pharmaceutics i.e., NLS Pharmaceutics and INVO Bioscience go up and down completely randomly.

Pair Corralation between NLS Pharmaceutics and INVO Bioscience

Given the investment horizon of 90 days NLS Pharmaceutics AG is expected to under-perform the INVO Bioscience. But the stock apears to be less risky and, when comparing its historical volatility, NLS Pharmaceutics AG is 2.49 times less risky than INVO Bioscience. The stock trades about -0.15 of its potential returns per unit of risk. The INVO Bioscience is currently generating about 0.03 of returns per unit of risk over similar time horizon. If you would invest  108.00  in INVO Bioscience on March 14, 2024 and sell it today you would lose (33.00) from holding INVO Bioscience or give up 30.56% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

NLS Pharmaceutics AG  vs.  INVO Bioscience

NLS Pharmaceutics

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days NLS Pharmaceutics AG has generated negative risk-adjusted returns adding no value to investors with long positions. Even with weak performance in the last few months, the Stock's basic indicators remain relatively invariable which may send shares a bit higher in July 2024. The latest agitation may also be a sign of long-running up-swing for the enterprise retail investors.

INVO Bioscience

Risk-Adjusted Performance

2 of 100

Weak

Compared to the overall equity markets, risk-adjusted returns on investments in INVO Bioscience are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. In spite of very uncertain basic indicators, INVO Bioscience displayed solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with NLS Pharmaceutics and INVO Bioscience

The main advantage of trading using opposite NLS Pharmaceutics and INVO Bioscience positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if NLS Pharmaceutics position performs unexpectedly, INVO Bioscience can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in INVO Bioscience will offset losses from the drop in INVO Bioscience's long position.

The idea behind NLS Pharmaceutics AG and INVO Bioscience pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Competition Analyzer module to analyze and compare many basic indicators for a group of related or unrelated entities.